|Combination antiretroviral therapy and the risk of myocardial infarction|
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
|Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study|
S Collins, T Mertenskoetter, E Loeliger, R Tressler, I Weller, N Friis-Møller, ...
Archives of internal medicine 166 (15), 1632-1641, 2006
|Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop.|
RF Speck, K Wehrly, EJ Platt, RE Atchison, IF Charo, D Kabat, ...
Journal of virology 71 (9), 7136-7139, 1997
|Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2−/− γc−/− mice|
S Baenziger, R Tussiwand, E Schlaepfer, L Mazzucchelli, ...
Proceedings of the National Academy of Sciences 103 (43), 15951-15956, 2006
|Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America|
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
|Folate receptor-α is a cofactor for cellular entry by Marburg and Ebola viruses|
SY Chan, CJ Empig, FJ Welte, RF Speck, A Schmaljohn, JF Kreisberg, ...
Cell 106 (1), 117-126, 2001
|Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection|
PY Bochud, M Hersberger, P Taffé, M Bochud, CM Stein, SD Rodrigues, ...
Aids 21 (4), 441-446, 2007
|Ageing with HIV: medication use and risk for potential drug–drug interactions|
C Marzolini, D Back, R Weber, H Furrer, M Cavassini, A Calmy, ...
Journal of antimicrobial chemotherapy 66 (9), 2107-2111, 2011
|Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses|
SY Chan, RF Speck, MC Ma, MA Goldsmith
Journal of virology 74 (10), 4933-4937, 2000
|Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology|
S Baenziger, M Heikenwalder, P Johansen, E Schlaepfer, U Hofer, ...
Blood 113 (2), 377-388, 2009
|TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection|
E Schlaepfer, A Audigé, H Joller, RF Speck
The Journal of Immunology 176 (5), 2888-2895, 2006
|Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections|
SK Rampini, GV Bloemberg, PM Keller, AC Büchler, G Dollenmaier, ...
Clinical Infectious Diseases 53 (12), 1245-1251, 2011
|Antigen kinetics determines immune reactivity|
P Johansen, T Storni, L Rettig, Z Qiu, A Der-Sarkissian, KA Smith, ...
Proceedings of the National Academy of Sciences 105 (13), 5189-5194, 2008
|Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 …|
A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ...
Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015
|Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1|
OT Keppler, FJ Welte, TA Ngo, PS Chin, KS Patton, CL Tsou, NW Abbey, ...
The Journal of experimental medicine 195 (6), 719-736, 2002
|V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1|
SY Chan, RF Speck, C Power, SL Gaffen, B Chesebro, MA Goldsmith
Journal of Virology 73 (3), 2350-2358, 1999
|Plasma cell toll‐like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production|
M Dorner, S Brandt, M Tinguely, F Zucol, JP Bourquin, L Zauner, C Berger, ...
Immunology 128 (4), 573-579, 2009
|Determinants of HIV-1 broadly neutralizing antibody induction|
P Rusert, RD Kouyos, C Kadelka, H Ebner, M Schanz, M Huber, DL Braun, ...
Nature medicine 22 (11), 1260-1267, 2016
|Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue|
JC Grivel, ML Penn, DA Eckstein, B Schramm, RF Speck, NW Abbey, ...
Journal of virology 74 (11), 5347-5351, 2000
|Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease|
B Schramm, ML Penn, RF Speck, SY Chan, E De Clercq, D Schols, ...
Journal of Virology 74 (1), 184-192, 2000